8,816,639 B Shares of Selectimmune Pharma AB (publ) are subject to a Lock-Up Agreement Ending on 27-OCT-2020. These B Shares will be under lockup for 490 days starting from 25-JUN-2019 to 27-OCT-2020. Details: The main owner and chairman of the board Catharina Svanborg, CEO Fredrik Herslow and Jan Zetterberg have committed to, unless with explicit permission from Artic Securities, not sell any shares in the period following 16 months after the first day of trading. The lock up agreement cover a total number of 8,816,639 shares, representing approx. 56 percent of the total number of shares following a fully subscribed Offer.